2006-2014年美国最可能受人乳头瘤病毒疫苗接种影响的年龄组肛门生殖器疣下降
研究利用2006至2014年美国私营健康保险参保者医疗索赔数据,估计15至39岁人群肛门生殖器疣(AGW)年患病率。结果显示15至19岁女性(APC=-14.1%,P<.001)、20至24岁女性(APC=-12.9%,P<.001)、25至29岁女性(APC=-6.0%,P=.001)及20至24岁男性(APC=-6.5%,P=.005)AGW患病率显著下降,其他性别年龄组稳定或上升。作者认为年轻男性患病率下降可能归因于女性接种疫苗的群体保护。
要点
- 15-19岁女性AGW患病率2008-2014年APC=-14.1%(P<.001)。
- 20-24岁女性2009-2014年APC=-12.9%,25-29岁女性APC=-6.0%(P=.001)。
- 20-24岁男性2009-2014年APC=-6.5%(P=.005),其他组稳定或上升。
核心结论
- 在最可能受HPV疫苗接种影响的女性年龄组及20至24岁男性中观察到AGW下降。
- 年轻男性患病率下降可能归因于女性接种疫苗的群体保护。
研究设计与样本
- 利用2006至2014年美国私营健康保险参保者医疗索赔数据,估计15至39岁人群AGW年患病率。
- AGW诊断依据以下之一:尖锐湿疣诊断;病毒性疣诊断合并良性肛门生殖器肿瘤诊断或肛门生殖器病变破坏/切除;AGW药物合并良性肛门生殖器肿瘤诊断或肛门生殖器病变破坏/切除。
主要发现
- 15至19岁女性2008至2014年AGW患病率年百分比变化(APC)=-14.1%(P<.001)。
- 20至24岁女性2009至2014年APC=-12.9%(P<.001),25至29岁女性APC=-6.0%(P=.001)。
- 20至24岁男性2009至2014年APC=-6.5%(P=.005)。
- 所有其他性别和年龄组AGW患病率上升或保持稳定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To detect decreases in anogenital warts (AGW) among sex and age groups likely to be affected by human papillomavirus vaccination. METHODS: We estimated annual AGW prevalence during 2006 to 2014 using health care claims among US private health insurance enrollees aged 15 to 39 years. We derived AGW diagnoses using 1 of the following: (1) condylomata acuminata diagnosis, (2) viral wart diagnosis combined with a benign anogenital neoplasm diagnosis or destruction or excision of an anogenital lesion, or (3) AGW medication combined with a benign anogenital neoplasm diagnosis or destruction or excision of an anogenital lesion. RESULTS: Prevalence decreased during 2008 to 2014 among females aged 15 to 19 years (annual percentage change [APC] = -14.1%; P < .001) and during 2009 to 2014 among women aged 20 to 24 years (APC = -12.9%; P < .001) and among women aged 25 to 29 years (APC = -6.0%; P = .001). We observed significant declines among men aged 20 to 24 years (APC = -6.5%; P = .005). Prevalence increased or was stable in all other sex and age groups. CONCLUSIONS: We observed AGW decreases among females in the age groups most likely to be affected by human papillomavirus vaccination and decreases in men aged 20 to 24 years. Decreased prevalence in young men is likely attributable to herd protection from vaccination among females.
引用
- Flagg EW, Torrone EA. Declines in Anogenital Warts Among Age Groups Most Likely to Be Impacted by Human Papillomavirus Vaccination, United States, 2006-2014. Am J Public Health. 2017. PMID: 29161070. doi:10.2105/AJPH.2017.304119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。